Baker Avenue Asset Management »

Cue Biopharma shares owned by Baker Avenue Asset Management

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Baker Avenue Asset Management from 13F filings

Historical chart of Baker Avenue Asset Management investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Baker Avenue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Baker Avenue Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $86k 32k 2.64
2023-09-30 $75k 32k 2.30
2023-06-30 $118k 32k 3.65
2023-03-31 $6.2k 1.8k 3.57
2022-12-31 $5.0k 1.8k 2.85

More positions owned by Baker Avenue Asset Management

Nvidia Corp Stock (NVDA)
Apple Stock (AAPL)
Powershares Qqq Tr Etf (QQQ)
Vanguard Small Cap Etf Etf (VB)
Microsoft Stock (MSFT)
Ishares Aggregate Bond Etf Etf (AGG)
Vanguard Total Bond Market Etf Etf (BND)
Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Dimensional Core Fixed Income Etf Etf (DFCF)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Netflix Stock (NFLX)
Ishares Russell 1000 Growth Etf Etf (IWF)
Amazon.com Stock (AMZN)
Tesla Motors Stock (TSLA)
Ishares S&p 500 Index Etf (IVV)

View all positions for Baker Avenue Asset Management

Top funds holding Cue Biopharma

Vanguard Group
Bleichroeder
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Monaco Asset Management SAM
Millennium Management
Bank of America Corporation
Sigma Planning
GSA Capital Partners
Stifel Financial
Charles Schwab Investment Management
Good Life Advisors
UBS Group
Bank of New York Mellon
HighTower Advisors

View all funds holding Cue Biopharma